Mannkind

Welcome To The Mannkind HUB On AGORACOM Edit this title from the Fast Facts Section
Home Videos Research Press Release Q&A Discussion
Discussion Parent
Back     Next
Threads Posts
Re: Just a reminder
Mannkind
about 12 years ago
1
in response to brentie98's message

The Type I trial participants that are asking to continue on Afrezza after the trial is over is encouraging and consistent with AU's Type II experience.

Back     Next
Please login to post a reply
brentie98
City
Rank
President
Activity Points
5496
Rating
Your Rating
Please Log In to Vote
Date Joined
03/19/2012
Social Links
Private Message
Mannkind
Stock Quotes
Symbol
MNKD
Exchange
NAZ
Shares
Industry
Technology & Medical
Website
Create a Post
Follow Hub
Disclaimer